john Posted May 3, 2004 Share Posted May 3, 2004 A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide ISA-51 (Montanide) in Patients with Cancer Expressing NY-ESO-1 of LAGE-1.. This study is being conducted in: - New York, NY (http://www.centerwatch.com/patient/stud ... 57653.html) Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.